Skip To Main Content
Michele Bartoletti on Muck Rack

Michele Bartoletti

As seen in: Emerging Infectious Diseases Journal, Nature, Wiley Online Library, Gut Journal, MDPI, BioRxiv, EClinicalMedicine, ersnet.org, Future Medicine, Clinical Microbiology and Infection and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michele

Contact Michele, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda

|
By Matteo Rinaldi, Alma Mater Studiorum, Michele Bartoletti
| EClinicalMedicine Verified
Keywords E faecium Bloodstream infection Delphi Management Evidence before this study We conducted a systematic review and meta-analysis of English-language studies published between January 2014 and January 2024 across PubMed-MEDLINE, EMBASE, and Scopus. The existing evidence revealed a fragmented landscape, predominantly composed of observational studies with a moderate risk of bias and a notable absence of randomised controlled trials.
Open in Who Shared Issue with article?

Recommendations on PCV20 vaccine in adults and at-risk populations

|
By Giovanni Sotgiu, Mariangela V. Puci, Michele Bartoletti, Francesco Blasi
| ersnet.org
Plain-language summary Streptococcus pneumoniae is one of the main causes of pneumonia and meningitis in children and adults. Invasive pneumonia and pneumonia acquired in everyday life are serious manifestations of pneumococcal infection. Adults and children with different immunocompromising conditions and the older population (over 65 years) have a 10 times higher risk of developing serious manifestations of pneumococcal disease, compared to a healthy population.
Open in Who Shared Issue with article?

Longitudinal Prediction of Drug Response in High-Grade Serous Ovarian Cancer Organoid Cultures Aligning with Clinical Responses

|
By Enrico Cavarzerani, Isabella Caligiuri, Michele Bartoletti, Giuseppe Corona
| BioRxiv
Abstract High-grade serous ovarian cancer (HGSOC) ranks among the most aggressive gynecological malignancies. Its high mortality stems from frequent recurrence post-primary treatments and development of platinum resistance. Since, traditional drug development via animal models is time-consuming and lacks reproducibility, in precision cancer medicine, primary patient- derived organoids (PDOs) offer a solution by replicating disease pathophysiology and expediting drug screening.
Open in Who Shared Issue with article?
See all 14 licensed articles (15 Total)